Ketim Technologies Named Semi-Finalist in the 2025 Australian Technologies Competition – Female Led Start-Up Award

Brisbane, Australia – June 7, 2025 – Ketim Technologies, a leader in biomarker-based diagnostics for perinatal mental health, has been named a semi-finalist in the Female Led Start-Up category of the 2025 Australian Technologies Competition (ATC), Australia’s premier technology awards program.

Selected from a record entry pool of 229 companies, Ketim Technologies is among 73 semi-finalists advancing to the next stage of the competition. As part of the program, Founder and CEO Dr. Clarissa Yates will attend the International Growth Masterclass & Networking Program in Sydney, gaining access to tailored mentoring from commercialisation experts, strategic advice from industry specialists, and connections with investors to refine the company’s growth strategy.

The ATC recognises and supports emerging Australian technology companies with the potential for global impact. For Ketim Technologies, the recognition highlights the company’s innovative approach to transforming maternal mental health care through its patented plasma protein biomarker panel and AI-driven analytics platform for the early detection of postpartum depression.

“It’s an honour for Ketim Technologies to be recognised among such a competitive field of innovators,” said Dr. Yates. “This program offers invaluable expertise and networks that will help us accelerate our mission to deliver precision mental health solutions to mothers worldwide.”

The competition will culminate in the Final Pitch & Awards Night on 17 September 2025 in Sydney.

For media inquiries, please contact:
Dr. Clarissa Yates
CEO, Ketim Technologies
clarissa.yates@ketim.com.au